Categories AlphaGraphs, Earnings, Health Care

Trxade Group (MEDS) delivers annual revenue growth of 130%

Company adds 328 new independent pharmacies to its network in Q4

Trxade (NASDAQ: MEDS) on Monday posted a 17% increase in fourth-quarter revenues to $2 million, riding on the strength of the Trxade Platform and Trxade Prime. The top-line, however, missed the average Wall Street consensus. 

Meanwhile, the company posted a wide net loss of $0.29 per share on goodwill impairment and inventory write-down, compared to analysts’ projection of EPS of $0.01.

Trxade Q4 2020 earnings

CEO Suren Ajjarapu said in a statement, “Despite the challenges of a global pandemic, we increased revenues by 130% for the year, a testament to our team’s continued innovation and development of our breakthrough digital healthcare services IT platform. ”

MEDS stock was up 2% during after-market hours on the stronger-than-expected revenues. The stock has gained 21% since the beginning of this year.

CEO TALKS: The story of Trxade Group (MEDS)

In the fourth quarter, the Tampa, Florida-based firm added 328 new independent pharmacies to its network. The company now has over 11,800 registered pharmacy members.

Trxade, which brings together independent pharmacies under one umbrella through its web-based purchasing platform, is present in all 50 states and is rapidly adding pharmacies to its network.

___

Prior performance

  • Trxade Group Q3 2020 earnings
  • Trxade Group Q2 2020 earnings results.
  • Trxade Group Q1 2020 earnings

Most Popular

Conagra (CAG) bets on consumer psychology to drive future demand and growth

Conagra Brands Inc. (NYSE: CAG) reported strong results for the third quarter of 2021 which surpassed expectations. Net sales increased 8.5% to $2.8 billion helped by the increase in at-home

Carnival Corp. (CCL): Vaccine rollout and pent-up demand provide optimism for the cruise operator

Shares of Carnival Corp. (NYSE: CCL) were down over 2% on Thursday. The company reported first quarter 2021 earnings results a day ago which missed expectations. Despite seeing a drastic

It might not be the right time to invest in American Express. Here’s why

Widespread flight cancellations and restrictions on the hotel industry during the pandemic have had a ripple effect on credit card companies and payment service providers. After going through a rough

Add Comment
Loading...
Cancel
Viewing Highlight
Loading...
Highlight
Close
Top